Completed OBSERVATIONAL NCT05403307

A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil

A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children Aged 5 to 11 Years in Brazil

Sponsor: Hospital Moinhos de Vento

Conditions COVID-19

Interventions CoronaVac COVID-19 vaccine Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine

Updated 4 times since 2022 Last updated: Nov 3, 2023 Started: Jun 8, 2022 Primary completion: Apr 30, 2023 Completion: Jul 17, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on COVID-19, this trial is completed. The trial is conducted by Hospital Moinhos de Vento and has accumulated 4 data snapshots since 2022. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2023 — Jul 2024 [monthly]

Completed

Status: Not Yet Recruiting → Completed
Jul 2022 — Dec 2023 [monthly]

Not Yet Recruiting

First recorded

Jun 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Moinhos de Vento
Inova Medical
Pfizer
Universidade Federal do Paraná

Data source: Hospital Moinhos de Vento

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toledo, Brazil